Find and Pitch Jounalists, Get Your Story Covered

Tags: AI machine learning patient care Psychedelic Pharmacy Psilocybin-Assisted Therapy

	Profile	Recent Articles on Subject
1	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	4 Things Employers Should Know About Psychedelic Medicines - 10 days ago What’s Next for Psychedelic Medicines? - 18 days ago
2	Kristen Monaco MedPage Today	More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 2 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - 11 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 12 months ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - 12 months ago
3	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 3 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 3 months ago A tough week for MDMA-assisted psychotherapy - 3 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 3 months ago Psychedelic investment continues to ramp up - 9 months ago
4	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 3 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 3 months ago They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better - 11 months ago
5	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Listen: Drug pricing drops & psychedelics under fire - 3 months ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Listen: Drug pricing drops & psychedelics under fire - 3 months ago
7	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	Listen: Drug pricing drops & psychedelics under fire - 3 months ago
8	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	MDMA therapy didn’t get FDA approval. Now what? - 3 months ago How should we sell psychedelics? - 4 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 8 months ago China’s emerging psychedelic scene looks a lot like Silicon Valley - 9 months ago Why psychedelics produce some of the most meaningful experiences in people’s lives - 12 months ago Robin Carhart-Harris studies psychedelics to understand the mind - 12 months ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago
9	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	The Promise of 'Magic Mushrooms' for Mental Health Is Real - 4 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Scientists Reveal What Your Brain Looks Like on Psilocybin - 4 months ago Experimental Drugs Grown in Space Return to Earth For Analysis - 9 months ago

Journalists covering Psychedelic Pharmacy